IRBESARTAN HCT MYLAN 300/12.5 irbesartan/hydrochlorothiazide 300/12.5 mg tablet bottle

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

hydrochlorothiazide, Quantity: 12.5 mg; irbesartan, Quantity: 300 mg

Fáanlegur frá:

Alphapharm Pty Ltd

INN (Alþjóðlegt nafn):

Hydrochlorothiazide,Irbesartan

Lyfjaform:

Tablet

Samsetning:

Excipient Ingredients: sodium lauryl sulfate; povidone; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; quinoline yellow aluminium lake; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 3350; iron oxide black

Stjórnsýsluleið:

Oral

Einingar í pakka:

7, 30, 90, 14

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

ABISART HCT is indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination.

Vörulýsing:

Visual Identification: A pink film-coated, oval, biconvex tablet debossed with "M" on one side of the tablet and "I34" on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Licence status A

Leyfisdagur:

2013-11-29

Vara einkenni

ABISART
HCT
_Irbesartan/Hydrochlorothiazide _
PRODUCT INFORMATION
NAME OF THE MEDICINE
Active ingredient:
Irbesartan
Hydrochlorothiazide
Chemical name:
2-butyl-3-[(2'-(1
_H_
-tetrazol-5-yl)biphenyl-
4-yl)methyl]-1,3-diazaspiro
[4,4]
non-1-
en-4-one
6-chloro-3,4-dihydro-2
_H_
-1,2,4-
benzothiadiazine-7-sulphonamide 1, 1-
dioxide
Structural formula:
Molecular formula:
C
25
H
28
N
6
O
C
7
H
8
N
3
S
2
O
4
Cl
Molecular weight:
428.5
297.7
CAS registry no.:
138402-11-6
58-93-5
DESCRIPTION
ABISART HCT (irbesartan/hydrochlorothiazide) is an oral
antihypertensive agent combining a nonpeptide
angiotensin II receptor (AT
1
subtype) antagonist, irbesartan, and a thiazide diuretic,
hydrochlorothiazide.
Irbesartan is a white to almost-white crystalline powder. It is a
relatively non-polar compound with a partition
coefficient (octanol-water) of 10.1 at a pH of 7.4. Irbesartan is
practically insoluble in water and slightly soluble
in alcohol and methylene chloride.
Hydrochlorothiazide is a white crystalline powder. It is slightly
soluble in water and freely soluble in sodium
hydroxide solution.
ABISART HCT 150/12.5 tablets contain 150 mg of irbesartan and 12.5 mg
of hydrochlorothiazide
ABISART HCT 300/12.5 tablets contain 300 mg of irbesartan and 12.5 mg
of hydrochlorothiazide.
ABISART HCT 300/25 tablets contain 300 mg of irbesartan and 25 mg of
hydrochlorothiazide.
The inactive ingredients in ABISART HCT tablets include: colloidal
anhydrous silica, magnesium stearate,
sodium lauryl sulfate, microcrystalline cellulose, pregelatinized
maize starch, povidone, lactose, croscarmellose
sodium, quinoline yellow aluminum lake, Opadry II complete film
coating system 32F540072 pink (ARTG no
109229) (150/12.5 mg and 300/12.5 mg) and Opadry II complete film
coating system 32F500006 purple (ARTG
no. 109227) (300/25 mg).
ABISART HCT – Product Information
2
PHARMACOLOGY
PHARMACODYNAMICS
Irbesartan is a specific antagonist of angiotensin II receptors (AT
1
subtype). Angiotensin II is an important
component of the renin-angiotensin system an